Protecting People From the Side Effects of Psychedelic Therapy

We’re in a shroom boom. One company, Compass Pathways, which plans to offer magic mushroom therapy, listed on the Nasdaq in November with a $1 billion valuation. New funds like Atai are raising hundreds of millions to invest in psychedelics. New companies are listing, new training programmes for therapists are launching, new states are preparing to legalize or decriminalize psychedelics.